Engineering the future of reproductive health.
Despite a growing infertility crisis, reproductive health has received limited focus and investment. Gameto is working on groundbreaking solutions that put women and families first.
Find a Fertilo Clinic
First Baby Born Using iPSC Technology
Gameto announced the first live birth following the use of Fertilo outside the United States, marking an important milestone for its cell-based egg maturation technology. Fertilo uses engineered ovarian support cells to support egg maturation outside the body and is currently being evaluated in the U.S. Phase 3 FIRST trial.
Fertilo has not been approved by the U.S. Food and Drug Administration (FDA) for safety or efficacy.
Explore Fertilo’s International Availability
Cell Therapy
to Help with Menopause
Despite the fact that over 1 billion women will experience menopause by 2025, few effective treatments exist.
With the help of our recent funding award through ARPA-H’s Sprint for Women’s Health Initiative, we believe our proprietary cell engineering will help delay the unwanted effects of menopause.
Learn More
Forbes
“Next Generation IVF Startup”
Gameto, co-founded by Under 30 alumna Dina Turner, has serious potential. Now it’s finally coming to market.
Read More
Endpoints News
“Gameto Cleared by FDA to Test Easier IVF Process”
Gameto has received permission from the FDA to investigate whether our ovary-in-a-dish technology can make IVF a less grueling process.
Read More
Engineering the future of reproductive health.
Despite a growing infertility crisis, reproductive health has received limited focus and investment. Gameto is working on groundbreaking solutions that put women and families first.
Find a Fertilo Clinic
First Baby Born Using iPSC Technology
Gameto’s iPSC-derived technology is designed to dramatically improve IVF and is showing promise in clinical studies.
Fertilo has not been approved by the U.S. Food and Drug Administration (FDA) for safety or efficacy.
Find a Fertilo Clinic
Cell Therapy
to Help with Menopause
Despite the fact that over 1 billion women will experience menopause by 2025, few effective treatments exist.
With the help of our recent funding award through ARPA-H’s Sprint for Women’s Health Initiative, we believe our proprietary cell engineering will help delay the unwanted effects of menopause.
Learn More
Forbes
“Next Generation IVF Startup”
Gameto, co-founded by Under 30 alumna Dina Turner, has serious potential. Now it’s finally coming to market.
Read More
Endpoints News
“Gameto Cleared by FDA to Test Easier IVF Process”
Gameto has received permission from the FDA to investigate whether our ovary-in-a-dish technology can make IVF a less grueling process.
Read More
From egg freezing and IVF, to ovarian disease and menopause
Gameto is a first-of-its-kind biotechnology company on a mission to address significant unmet needs for women and families throughout their reproductive years — and beyond.
Transforming reproductive health using modern science
Gameto’s groundbreaking cell engineering platform has the potential to solve many of the problems at the heart of the global infertility crisis.
The first application of our technology, Fertilo, aims to improve the current IVF and egg freezing landscape using engineered ovarian support cells.
WHAT IS FERTILO ?
WHAT IS FERTILO ?
IVF and Egg Freezing, Simplified
Fertilo enables egg maturation outside the body. It is being developed with the goal of reducing the duration of ovarian stimulation needed and improving the fertility treatment experience for patients. In the U.S., it is an investigational biologic currently advancing through a Phase 3 clinical trial, in which it will be evaluated for safety and efficacy. It is not approved for marketing in the US.
How Fertilo Works
STAGE 1
Immature Eggs Retrieved
Collected after 1–3 days of minimal hormone stimulation.
STAGE 2
Fertilo Maturation Ex Vivo
Engineered cells nurture eggs in the lab for about 24 hours.
STAGE 3
Mature Eggs Ready
Fertilized or frozen within 2–6 hours after maturation, similar to current standard laboratory procedures.
ACCESS FERTILO
ACCESS FERTILO
A Better IVF Experience, Designed for You
Fertilo is a cell-based technology being developed with the goal of reducing the duration of ovarian stimulation and improving the fertility treatment experience. Whether you are exploring your options, interested in learning about the U.S. clinical trial, or seeking information about Fertilo’s international availability, we are here to help you learn more.
Clinical Trials
Explore opportunities to participate in the U.S. Phase 3 FIRST clinical trial evaluating investigational Fertilo technology.
Fertilo Clinics
See where Fertilo is available worldwide.
Find A Clinic
Register Interest
Sign up to receive the latest updates on Fertilo.
Get Updates
Because women and families deserve more.
Infertility impacts 1 in 6 people worldwide, including our own friends, family, and colleagues. This fight is personal for us, because it’s personal for everyone.
We believe everyone deserves access to solutions that give them the best chance at achieving their family planning goals and dreams.
Our Science
Gameto in the News
See More Stories